FORYOU MEDICAL New Silver Wound Gel Gets FDA Approval

In 2022, FORYOU MEDICAL 's work in product registration was affirmed by many parties. At the end of April, we received good news again,  LUOFUCON® Silver Wound Gel independently developed by the company has passed the FDA certification to enter the U.S. market, which approval number K211123, further enriches the company's silver containing dressing product line and provides more choices for clinical care.

LUOFUCON® Silver Wound Gel is a sterile, water-based amorphous hydrogel composed of hydrophilic polymer and silver compound. The gel helps to maintain a moist wound environment, while the silver compound acts as a preservative to inhibit the growth of microorganisms in the gel during usage.

In-vitro preservative test of LUOFUCON® Silver Wound Gel was conducted according to USP <51> Antimicrobial Effectiveness Testing and it showed more than 4 log reduction of high inoculated level of tested microorganisms within 24 hours. And LUOFUCON® Silver Wound Gel keeps inhibiting microorganisms’ growth for 28 days.

LUOFUCON® Silver Wound Gel, used in combination with a secondary moisture-retentive dressing, can effectively promote the autolytic debridement, play a good role in softening scab and inanimate tissue, alleviate the tension of patients caused by conservative sharp debridement and mechanical debridement, and provide more high-quality choices for clinical nursing programs.

For you, for us, for life!

Welcome to contact our sales engineer for more details about LUOFUCON® Silver Wound Gel.
Tel：+86 752-5302185
Fax：+86 752-5302020